Afuco™ Anti-Human HLA-DR βchain ADCC Therapeutic Antibody (1D09C3), ADCC Enhanced
Anti-HLA-DR βchain ADCC Enhanced Antibody (1D09C3) is an ADCC enhanced antibody produced by our Afuco™ platform. 1D09C3 is a human monoclonal IgG4-type antibody against human leukocyte antigen-DR (HLA-DR) which has demonstrated pro-apoptotic activity against lymphoid tumors in vitro and in vivo. 1D09C3 could be administered safely in patients with advanced B cell malignancies.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-346CL |
| Pricing | Inquiry |
| Host | Human |
| Target | HLA-DR βchain |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |